When it comes to Medicaid, only a dozen or so state programs cover GLP-1s for weight loss
is the only company in the United States with FDA-approved products containing semaglutide, identified under the trade names Rybelsus, Ozempic, and Wegovy
An effective treatment might require either utilization of multiple drugs which target the individual pathological processes which underlie the neurodegenerative disease or the use of a single agent which could influence multiple pathological processes
Obesity, binge eating, and metabolic syndrome frequently coexist with anxiety, depression, and chronic stress, yet most metabolic therapies target peripheral pathways while neglecting central drivers of behavior
LegitScript Certification is a credential awarded to healthcare-related businesses and websites that demonstrate a commitment to legality, quality care, and patient safety
Using our proprietary technology, the insurance checker is one of the only available tools to help you navigate the hurdles of insurance coverage for GLP-1s